{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Amphetamine Sulfate Tablets are a generic prescription drug containing amphetamine sulfate, a central nervous system stimulant. It's available in 5mg and 10mg oral tablets and is classified as a Schedule II controlled substance. Manufactured by Dr. Reddy's Laboratories Inc., it's used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Amphetamine sulfate tablets \u2014 ANDA 212582 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212582", "mediaType": "text/html", "title": "Amphetamine sulfate tablets"}], "identifier": "ANDA212582", "issued": "2016-09-16", "keyword": ["medications", "health-care", "drug", "pharmaceuticals", "fda"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Amphetamine sulfate tablets"}